Physician Tool for Patient Discussion: Learning to Identify and Actively report Adverse Events with Lorlatinib
Easy to understand graphics will help to facilitate discussion between patients and their oncology healthcare team to manage adverse events.
Download this Physician Tool for Patient Discussion to empower patients and their caregivers to identify and actively report ALK TKI-related adverse events.
Supported by unrestricted educational funding from Pfizer.
